Acino Holding AG : Acino's shareholders approve nearly all motions of the Board of Directors

NEWS RELEASE - PRESSEMITTEILUNG

Acino's shareholders approve nearly all motions of the Board of Directors Basle, April 4, 2013, 12.00 hrs - At the Annual General Meeting (AGM) held in Basle today, the shareholders of Acino Holding AG endorsed nearly all agenda items.

In particular, the shareholders consented to the proposed allocation of the balance

sheet profit to the legal reserves and the waiving of a dividend for the year 2012. On the other hand, the Annual General Meeting did not approve the creation of a new authorized capital.

In the election, the shareholders confirmed Jürg Michel as a Member of the Board of

Directors for another three-year term of office.

The shareholders also approved the transfer of the company's domicile from Basle to nearby Aesch (Canton Baselland), the site acquired from Mepha which houses R&D units, a manufacturing plant and Acino's central functions.

In an advisory vote conducted for the third time, the shareholders also ratified the company's remuneration system for Members of the Board of Directors and Group Management.

The 149 attending shareholders represented 1 552 449 shares or 45% of the share capital of 3 460 000 issued shares in total.

Acino - Delivering Health

Acino (SIX: ACIN), a Swiss-based pharmaceutical company, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino is a leader in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provides customized one-stop solutions from product development and registration to contract manufacturing, packaging and logistics. Under the brand
"Acino Switzerland", Acino markets Swiss-quality medicines in up and coming economies, currently in 80 countries in the Middle East, Africa, Latin America and Asia. The Acino Group is head- quartered in Basle and will move its domicile to Aesch BL in the course of 2013. At present, the Acino Group has about 836 employees and generated annual revenues of EUR 257 million in 2012.

Contact Calendar

Robert Schmid
Media & Investor Relations Phone [phone] [e-mail]
www.acino-pharma.com

30.7.2013 Half-year Report as of June 30, 2013

Acino Holding AG

Erlenstrasse 1

CH-4058 Basle

Phone [phone]

Fax [phone] www.acino-pharma.com